Sort
40,608 grants matching “prostate cancer”
Enhancing olfactory receptor expression for biochemical studies of odorant-receptor interactions
$658,057Hiroaki Matsunami · Duke University · R01 · FY2025 · DC
Enhancing olfactory receptor expression for biochemical studies of odorant-receptor interactions
$658,057Hiroaki Matsunami · Duke University · R01 · FY2024 · DC
Drug Development of Skp2 PROTACs in Cancer
$658,049Hong-Yu Li · University Of Texas Hlth Science Center · R01 · FY2023 · CA
Biological functions of chromosomal proteins
$657,985Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Beyond Binding: Personalized Multi-omic Neoantigen Identification
$657,934Rachel Karchin · Johns Hopkins University · R01 · FY2025 · CA
Transrectal Histotripsy for Focal Ablation of Prostate Cancer
$657,875George R Schade · University Of Washington · R01 · FY2023 · CA
Image guided intervention system for pancreatic cystic lesions
$657,842Nicusor Iftimia · Physical Sciences, Inc · R44 · FY2011 · CA
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)
$657,837Debra L Friedman · Vanderbilt University Medical Center · R01 · FY2021 · CA
Imputation-based approach to identify low frequency variants in prostate cancer
$657,827Fredrick Ray Schumacher · University Of Southern California · U01 · FY2014 · CA
Phenotypic marker-guided development of selective antimetastasis therapeutic leads
$657,810Sui Huang · Northwestern University At Chicago · R01 · FY2022 · CA
Translating HP 13C MRI as a Novel Paradigm for Assessing Drug Target Inhibition
$657,802Daniel B Vigneron · University Of California, San Francisco · R01 · FY2017 · CA
Improving Patient Outcomes Through System Navigation
$657,693Peter C Raich · Denver Health And Hospital Authority · U01 · FY2009 · CA
Multifunctional Regulation of Prostate Cancer Metabolism by Sigma1 Modulators
$657,666Felix Jinhyun Kim · Thomas Jefferson University · R01 · FY2020 · CA
"Novel Mouse Models for Quantitative Understanding of Baseline and Therapy-Driven Evolution of Prostate Cancer Metastasis"
$657,652Dawid Grzegorz Nowak · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
NCCU/BBRI-DUKE/UROLOGY PARTNERSHIP IN PROSTATE CANCER RESEARCH
$657,630North Carolina Central University · · FY2008 · Department of Defense
Multi-Site Development & Evaluation of a Quantitative 3D Hyperpolarized C-13 MRI Clinical Prostate Cancer Exam
$657,613James A Bankson · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
NATURAL HISTORY OF PROSTATISM--THE OLMSTED COUNTY STUDY
$657,595Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2001 · DK
Growth Factors and Prostate Cancer Risk
$657,549Brigham And Women'S Hospital · R01 · FY2004 · CA
Diagnosing clinically-significant prostate cancer in African American men: Systematic random versus MR-image-fusion guided biopsy
$657,431Inderbir Gill · University Of Southern California · R01 · FY2019 · CA
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer
$657,403Hyung L Kim · Cedars-Sinai Medical Center · R01 · FY2024 · CA
Genome-wide sequencing of prostate cancer in men of African ancestry
$657,327Christopher Alan Haiman · University Of Southern California · R01 · FY2016 · CA
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy
$657,305Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Project 3: Spherical Nucleic Acids as Immunotherapeutic Agents for Prostate Cancer
$657,226Chad A. Mirkin · Northwestern University At Chicago · U54 · FY2016 · CA
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
$657,156William C Hahn · Broad Institute, Inc. · R01 · FY2025 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$657,066James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA